Viral and Immunological MalignanciesThe precise relationship between viral infection and malignancy remains an epidemiologic association and the subject of active investigation. Nonmalignant hematologic disorders have a similarly complex relationship with cancer-associated viruses and may offer insight into the pathogenesis of oncogenesis. This book explores the relationships between viral infections, immune impairments and the hematologic and malignant diseases, particularly against the backdrop of the HIV epidemic. By extending the scope to all of viral oncology the editors provide an invaluable resource on tumors related to other viruses other than HIV, particularly carcinomas of the cervix and anus with HPV and tumors of the liver with the various hepatitis viruses. |
Contents
1 | |
26 | |
Human Herpesvirus 8Kaposis SarcomaAssociated Herpesvirus Biology | 40 |
Epidemiology of Kaposis SarcomaAssociated Herpesvirus Infection | 67 |
Clinical Features and Management of Kaposis Sarcoma | 89 |
Castlemans Disease | 108 |
Primary Effusion Lymphomas Biology and Management | 122 |
EpsteinBarr Virus Infection and the Pathogenesis of Cancer | 130 |
Human PapillomavirusRelated Malignancies With and Without HIV Epidemiology Diagnosis and Management | 224 |
Viral Hepatitis and Hepatocarcinogenesis | 242 |
Screening for Hepatocellular Cancer Current Strategies and Controversies | 257 |
Hepatocellular Cancer Diagnosis and Management | 268 |
Simian Virus 40 and Human Malignancy | 297 |
The Human TLymphotropic Leukemia Viruses 1 and 2 | 326 |
NonAIDSDefining Cancers in HIVInfected Individuals | 359 |
Anemia in HIV Infection | 380 |
Nasopharyngeal Cancer Diagnosis and Management | 149 |
Management of Primary Central Nervous System Lymphoma and Primary Intraocular Lymphoma | 166 |
Diagnosis and Management of NonHodgkins Lymphoma and Hodgkins Lymphoma | 180 |
Pathogenesis of Human PapillomavirusRelated Malignancies | 206 |
Other editions - View all
Common terms and phrases
Acquir Immune Defic AIDS AIDS-related anal cancer anemia antibodies antigen antiretroviral therapy apoptosis associated ATLL Biol biopsy blood Castleman's disease cellular cervical cancer chemotherapy cirrhosis Clin Oncol clinical cycle cytokines detection diagnosis drug encoded Epidemiology Epstein-Barr virus evaluation gene expression genome HAART hepatitis hepatocellular carcinoma HIV-infected patients HIV-positive patients Hodgkin's disease HTLV-I human herpesvirus human immunodeficiency virus human papillomavirus Immune Defic Syndr Immunol incidence increased induced infection inhibitors inhibits Int J Cancer Kaposi's sarcoma Kaposi's sarcoma-associated herpesvirus KSHV Lancet latent lesions leukemia liver LMP1 lung cancer lymphocytes lymphotropic lytic malignancies mice nasopharyngeal carcinoma neoplasia non-Hodgkin's lymphoma Oncogene Pathol PCNSL pesvirus phoma population prevalence primary protein radiation receptor replication reported risk factors rituximab role screening seroprevalence squamous stage survival syndrome tion tissue transcription transmission transplantation treatment tumor tumor cells vaccine viral Virol virus type women